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Maintenance and manipulation of large DNA and RNA virus genomes had presented an obstacle for virological research. BAC
vectors provided a solution to both problems as they can harbor large DNA sequences and can eﬃciently be modiﬁed using well-
established mutagenesis techniques in Escherichia coli. Numerous DNA virus genomes of herpesvirus and pox virus were cloned
intomini-Fvectors.Inaddition,severalreversegeneticsystemsforRNAvirusessuchasmembersofCoronaviridaeandFlaviviridae
could be established based on BAC constructs. Transfection into susceptible eukaryotic cells of virus DNA cloned as a BAC allows
reconstitution of recombinant viruses. In this paper, we provide an overview on the strategies that can be used for the generation
of virus BAC vectors and also on systems that are currently available for various virus species. Furthermore, we address common
mutagenesistechniquesthatallowmodiﬁcationofBACsfromsingle-nucleotidesubstitutionstodeletionofviralgenesorinsertion
of foreign sequences. Finally, we review the reconstitution of viruses from BAC vectors and the removal of the bacterial sequences
from the virus genome during this process.
1.Introduction
Formanyyears,geneticmanipulationofthegenomesoflarge
DNA viruses was extremely tedious and dependent on rare
recombinationeventsinsusceptibleeukaryoticcells.Infected
cellsweretransfectedwithplasmidsorlinearDNAfragments
containing a selection marker ﬂanked by sequences homolo-
gous to the target locus. This process allowed the deletion
or mutation of the gene of interest in the virus genome.
However, puriﬁcation of resulting recombinant viruses was
laborious and often required several passages. Deletion of
essential viral genes was usually not feasible due to the strong
selection for progeny viruses that eﬃciently replicate in vitro.
Constant selective pressure during serial virus passage often
resulted in compensatory mutations in the viral genome. To
overcome the obstacle of essentiality, transcomplementing
cell lines were generated that would compensate for the
absence of the gene in the virus context. This solution would
work in most cases but was not always possible due to the
toxicity of some viral proteins. A solution to the problems
was the maintenance and modiﬁcation of virus genomes
in bacteria where the accuracy of the bacterial polymerase
allows clonal maintenance of viral sequences in E. coli.A s
viral promoters are not functional in bacteria, there is no
selective pressure on the virus genome in E. coli.I nr a r e
cases, high-copy plasmids containing virus sequences can
be toxic for bacteria; however, this problem could also be
overcome by the use of single or low-copy vectors, such as
bacterial artiﬁcial chromosomes (BACs). Another advantage
of BAC replicons is the high capacity of up to 300kbp that
is required for the cloning of large DNA and RNA virus
genomes. Maintenance and faithful replication of the BAC
construct in E. coli are facilitated by components encoded in
the minimal fertility factor replicon (mini-F), the backbone
of the BAC vector. Replication of the BAC is initiated at
the origin of replication S (oriS) and stringently regulated
by the repE and repF gene products encoded in the mini-F.
Resulting copies of the replicon are subsequently allocated
to the two daughter cells. This dynamic process is facilitated
by the mini-F-encoded proteins SopA and SopB and the
centromere region sopC [1]. Bacterial antibiotic resistance
cassettes present in the BAC vector backbone allow the2 Journal of Biomedicine and Biotechnology
selection in E. coli. Besides the essential sequences required
for replication and maintenance, many BAC vectors harbor
a variety of expression cassettes that allow visualization
of BAC-containing sequences in transfected cells selection
in mammalian cells and, hence, ease the generation of
recombinant viruses that contain the mini-F.
The major advantage of the maintenance of virus
genomes in BAC vectors is the availability of well-established
mutagenesis techniques in E. coli. Over the last decade, a
number of methods have been developed that allow the
generation of virtually any mutation in a virus genome.
Within a few days, genes or sequence elements can be
removed. Foreign sequences can readily be inserted into the
genome, allowing detection of viral proteins via epitope tags,
or expression of foreign genes for development of vector
vaccines [2–7]. Furthermore, reporter genes such as the
green ﬂuorescent protein (GFP) can be incorporated into the
viral genome to visualize infected cells in vitro and in vivo
or fused to a viral protein to determine its localization in
living cells [3, 6, 8]. In addition, luciferase reporter genes
can be inserted which allows tracking of the virus in live
animals [9, 10]. Even single nucleotides can be edited in the
virus genome, a modiﬁcation that is almost impossible with
conventional virus mutagenesis in mammalian cells.
U n t i ln o w ,B A C sh a v eb e e ng e n e r a t e df o ral a r g en u m b e r
of DNA but also some RNA viruses. In this paper we provide
an overview on strategies for the generation of virus BAC
clones for both DNA and RNA viruses. Furthermore, we
review the viral BAC systems that are currently available to
the research community. As modiﬁcation of virus genomes
is an important tool in virological research, we outline the
available mutagenesis techniques for viral BAC vectors. Last
but not least, we describe various techniques that can be
used for the removal of the mini-F from viral genomes upon
reconstitution in eukaryotic cells.
2. Generation of Bacterial Artiﬁcial
Chromosomes (BACs)
2.1. Homologous Recombination in Mammalian Cells. One of
the most common methods for the insertion of the mini-F
vector into the genomes of DNA viruses utilizes the recom-
bination machinery of mammalian cells. For this approach,
a transfer vector is generated that harbors the mini-F
cassette ﬂanked by sequences identical to the insertion site
in the virus genome. The choice of the mini-F insertion
site is critical as essential genes may not be aﬀected in the
process [11]. Circular or linearized transfer plasmid is either
transfected into virus-infected cells or is co-transfected with
virus genomic DNA. In a small portion of transfected cells,
a recombination event facilitated by cellular recombinases
allows the insertion of the mini-F sequences into the
virus genome. Upon virus reconstitution, cells producing
recombinantvirusescanbevisualizedbyﬂuorescentmarkers
such as green ﬂuorescent protein (GFP), which is often
introduced in standard mini-F plasmids. Alternatively, cells
infected with recombinant viruses can be enriched using
selection markers such as gpt, hygromycin, or neomycin
that are encoded by resistance genes present in the mini-F
vector. Upon puriﬁcation of recombinant viruses harboring
mini-F vector sequences, susceptible cells are infected and
circular virus DNA is isolated. In many cases, viral DNA
is prepared using a method previously published by Hirt
(1967), which uses fractionated precipitation with SDS and
NaCl to separate viral from cellular DNA [12]. Residual
cellular DNA can be fragmented using restriction enzymes
that do not cut in the virus genome. Resulting linearized
DNA may be removed by incubation with λ-exonuclease, an
enzyme that exclusively digests linear DNA, leaving circular
DNA intact [13]. This approach allows an enrichment of
circular virus DNA. Isolated viral DNA harboring the mini-
F is then electroporated into E. coli K12 strains, and BAC-
containing bacteria are selected using antibiotic resistance
genes present in the mini-F backbone [14]. Resulting BAC
clones are routinely analyzed by restriction fragment length
polymorphism (RFLP) to ensure the integrity of the virus
genome. In addition, the insertion site of the mini-F
is sequenced to determine if mutations that are present
may have occurred in the recombination process. Recently,
sequencing of entire BAC clones has become an attractive
alternative, as the cost of high-throughput sequencing has
dropped dramatically.
2.2. Cosmid-Based Approach. An alternative strategy often
used for BAC generation of cell-associated viruses utilizes
cosmid vectors to initially maintain overlapping parts of
the genome of DNA viruses. The mini-F is subsequently
inserted into one of the cosmids by ligation or homologous
recombinationin E.coli.Transfectionoftheoverlapping cos-
mids into eukaryotic cells results in recombination between
homologous sequences and reconstitution of infectious
virus. During the process, the cosmid containing the mini-
F cassette is incorporated into the virus genome, all resulting
virusesharborthemini-F,andnolaboriousselectionstepsto
obtain recombinant clones are required. As described above,
circular virus DNA is then isolated and transformed into
E. coli and clones are screened for the integrity of the virus
genomes they contain [13].
2.3. In Vitro Ligation. Recently, it has been shown that the
mini-F replicon can be inserted into herpesvirus genomes
by direct ligation [29]. For this purpose, concatemeric
virus DNA is isolated from herpesvirus infected-cells and
cleaved with a restriction enzyme that cuts only in a
single locus within the virus genome. The resulting full-
length viral genome is then ligated with a linearized mini-F
vector containing compatible DNA ends. To avoid ligation
of the mini-F with cellular fragments, restriction enzymes
that recognize an interrupted palindrome and allow the
generation of desired directional sticky ends such as SﬁI or
BstXIcanbeused.Thisstrategyhasbeensuccessfullyapplied
to the generation of a BAC system for human herpesvirus 6A
(HHV-6A) [29]. There are, however, several disadvantages
to this method. Firstly, the strategy requires a completely
sequenced virus genome in order to determine potential
restriction sites that can be used for the ligation procedure.
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restriction site that is suitable for the strategy. Thirdly, the
mini-F insertion site is limited to the location of the unique
restriction site. Insertion into open reading frames (ORFs)
or promoters of the virus genome can impair or abrogate
infectivity of BAC-derived viruses. Last but not least, ligation
and transformation procedures for large BAC vectors are
very ineﬃcient, therefore hampering cloning attempts.
2.4. Strategy for Poxviruses. As described in Section 2.1,
insertion of the mini-F sequences into the poxvirus genome
can be facilitated by the cellular recombination machinery
in mammalian cells [40–43]. However, unlike herpesviruses,
poxviruses do not produce a circular form of the virus
genome during replication. This poses a major hurdle for
the transfer of the recombinant poxvirus constructs into
E. coli. To overcome the problem, infected cells are treated
with isatin-β-thiosemicarbazone that promotes accumula-
tion of nonresolved, genomic concatemers [40–44]. For the
generation of some poxvirus BAC clones, it was suﬃcient
to transform E. coli with concatemeric DNA, a procedure
that likely resulted in a recombination event allowing
circularization of the replicon [40, 43]. Alternatively, isolated
poxvirus DNA was circularized prior to transformation of
E. coli using the Cre/loxP- or Flp/FRT-recombination system
that will be further described in Section 4.3 [41, 42].
2.5. Generation of BACs for RNA Viruses. BAC vectors
can also be used to maintain and modify the genome of
RNA viruses. This has been successfully shown for several
members of the Coronaviridae and Flaviviridae [45–50]. To
generate a full-length BAC clone for these nonsegmented
RNA viruses, viral RNA is isolated from infected cells and
cDNA synthesized using reverse transcriptase. Full-length
genomic cDNA can be puriﬁed by gel electrophoresis and
subsequently cloned into a mini-F vector by a standard
ligation reaction. If synthesis of a full-length cDNA is not
possible due to the size of the virus genome, fragments of
the genome can be transcribed into cDNA and subsequently
combined by ligation to obtain a complete virus genome
[51]: similar to the situation for DNA viruses, some RNA
viruses can be reconstituted by transfection of (cloned)
viral nucleic acid into eukaryotic cells. Expression of viral
genomic RNA can be facilitated by cellular RNA polymerase
II under the control of the major immediate-early promoter
of human cytomegalovirus (HCMV) [45, 46]. Alternatively,
a T7 promoter can be employed to drive the expression of
viral RNA, where T7 polymerase is either stably expressed
in the cell line used for virus reconstitution or delivered in
trans by transfection or using vaccinia virus as a delivery
vehicle[52,53].Correctprocessingofthe3 -endsofthevirus
genomes is often achieved by the bovine growth hormone
(BGH) terminator and sequences of the hepatitis delta virus
(HDV) ribozyme [45, 46, 49]. Full-length viral RNA can
also be transcribed in vitro using a T7 promoter/polymerase
system with the virus BAC clone as a template. Transfection
into susceptible cells of the viral RNA transcribed in vitro
usually allows virus reconstitution [51].
Currently, several laboratories are working on the gen-
eration of BAC systems for segmented RNA viruses. For
this approach, cDNA clones of viral RNA segments are
combined into a BAC vector. Alternatively, segments of the
virus genome can be generated by de novo synthesis [54].
Transcription of genomic RNA of segmented viruses utilizes
similar promoter/terminator systems as described above for
nonsegmented RNA viruses. For example, all eight inﬂuenza
A virus genome segments were recently cloned into a single
high-capacity vector. This system allows a more eﬃcient
reconstitution of the virus in eukaryotic cells and could be
used for the production of recombinant inﬂuenza vaccines
[55].
3. BACs Available for Members of
VariousHerpesvirusFamilies
3.1. Herpesvirales. Over the last two decades, BAC vectors
have become an important tool for herpesvirus research. In
1997, the ﬁrst virus BAC system was developed by Messerle
and colleagues for the murine cytomegalovirus (MCMV),
one of the largest herpesviruses with a genome size of
230kbp [14]. Shortly after the generation of the MCMV
BAC, the technology was applied to many other species in
the order Herpesvirales. These include numerous members
of the Herpesviridae with species from all three subfamilies,
Alpha-, Beta-a n dGammaherpesvirinae (Table 1). Until now,
BAC clones have been generated for all human herpesviruses
withtheexceptionofhumanherpesvirus7(HHV-7).Besides
the Herpesviridae, two members of the Alloherpesviridae,
koi herpesvirus and channel catﬁsh herpesvirus, have been
cloned into mini-F vectors [38, 39]. All in all, BAC systems
are available for at least 27 herpesvirus species that infect
hosts as diverse as ﬁsh, birds, and humans (Table 1). For
many of these herpesviruses, several strains have been cloned
as BACs, allowing the maintenance and manipulation of
laboratorystrainsandclinicalisolateswithvaryingvirulence.
The plethora of BAC-based genetic systems has eased the
analysis of herpesvirus-encoded genes and has immensely
contributed to our understanding of the viruses’ life cycles
and pathogenesis.
3.2. Poxviridae. So far, several full-length poxvirus genomes
of the genus Orthopoxvirus have been cloned into BAC vec-
tors. The ﬁrst BAC construct was generated for the vaccinia
virus strain Western Reserve [41, 56]. After this proof-of-
principleforpoxvirusBACgeneration,twoBACvectorswere
developed for the highly attenuated modiﬁed vaccinia virus
Ankara (MVA) and one for its more virulent parental strain,
chorioallantois vaccinia virus Ankara (CVA). The MVA and
CVA BAC constructs allowed an analysis of the eﬀect of
six major deletions present in MVA genome on poxvirus
pathogenesis and the diﬀerences in cellular tropisms of MVA
and CVA [40, 42]. Recently, a BAC clone was established for
cowpox virus (CPXV), a zoonotic, rodent-borne poxvirus
that has the largest and most complete genome of all
orthopoxviruses [43]. The broad spectrum of mutagenesis
techniques described in Section 4 facilitated many studies
that shed light on the role of viral genes in the poxvirus
lifecycle and allowed the establishment of recombinant next-
generation vector vaccines [40, 43, 56, 57].4 Journal of Biomedicine and Biotechnology
Table 1: Overview of published BAC systems for species of the order Herpesvirales. Commonspecies names, corresponding acronyms, taxon
names, genome sizes, and references for the ﬁrst BAC construct of every species are given. ∗Common names and acronyms are as they were
used in the listed reference.
Virus Acronym∗ Taxon name Genome size Reference
Common name∗
Herpesviridae
Alphaherpesvirinae
Bovine herpesvirus 1 BoHV-1 Bovine herpesvirus 1 135kbp [15]
Canine herpesvirus CHV Canid herpesvirus 1 160kbp [16]
Equine herpesvirus 1 EHV-1 Equid herpesvirus 1 150kbp [17]
Equine herpesvirus 4 EHV-4 Equid herpesvirus 4 146kbp [18]
Felid herpesvirus 1 FeHV-1 Felid herpesvirus 1 136kbp [19]
Herpes simplex virus 1 HSV-1 Human herpesvirus 1 152kbp [20]
Herpes simplex virus 2 HSV-2 Human herpesvirus 2 155kbp [21]
Herpesvirus of turkey HVT Meleagrid herpesvirus 1 160kbp [22]
Marek’s disease virus MDV Gallid herpesvirus 2 178kbp [23]
Pseudorabies virus PRV Suid herpesvirus 1 142kbp [24]
Simian varicella virus SVV Cercopithecine herpesvirus 9 125kbp [25]
Varicella-zoster virus VZV Human herpesvirus 3 125kbp [26]
Betaherpesvirinae
Guinea pig cytomegalovirus GPCMV Caviid herpesvirus 2 220kbp [27]
Human cytomegalovirus HCMV Human herpesvirus 5 229kbp [28]
Human herpes virus 6A HHV-6A Human herpesvirus 6 159kbp [29]
Mouse cytomegalovirus MCMV Murid herpesvirus 1 230kbp [14]
Rhesus cytomegalovirus RhCMV Macacine herpesvirus 3 221kbp [30]
Gammaherpesvirinae
Bovine herpesvirus 4 BoHV-4 Bovine herpesvirus 4 171kbp [31]
Epstein-Barr virus EBV Human herpesvirus 4 172kbp [32]
Herpesvirus saimiri HVS Saimiriine herpesvirus 2 113kbp [33]
Kaposi’s sarcoma-associated herpesvirus KSHV Human herpesvirus 8 137kbp [34]
Murine gammaherpesvirus 68 MHV-68 Murid herpesvirus 4 119kbp [8]
Rhesus lymphocryptovirus rhLCV Macacine herpesvirus 4 171kbp [35]
Rhesus rhadinovirus RRV Macacine herpesvirus 5 133kbp [36]
Unassigned
Duck enteritis virus DEV Anatid herpesvirus 1 158kbp [37]
Alloherpesviridae
Channel catﬁsh herpesvirus CCV Ictalurid herpesvirus 1 134kbp [38]
Koi Herpesvirus KHV Cyprinid herpesvirus 3 295kbp [39]
3.3. RNA Viruses. The establishment of stable genetic sys-
tems for RNA viruses was, and in some cases still is, one
of the major challenges. Cloning of cDNA sequences into
expression vectors allows maintenance and manipulation
of the RNA virus genomes. However, in case of large
nonsegmented RNA viruses, the capacity of regular plasmids
is often not suﬃcient. Furthermore, high-copy vectors
containing virus-derived cDNA fragments can be instable
or exhibit toxic eﬀects on the bacterial host. To circumvent
the obstacles, cDNAs of several nonsegmented viruses were
inserted into mini-F vectors. The ﬁrst BAC of an RNA
virus was developed by Almaz´ an and colleagues in 2000 for
transmissible gastroenteritis coronavirus (TGEV), a member
of the Coronaviridae [45]. The large TGEV genome of almost
29kbp was transcribed into cDNA and was successfully
cloned and eﬃciently maintained as a BAC construct. In
the following years, BAC systems were generated for other
coronaviruses such as human coronavirus (HCoV) andJournal of Biomedicine and Biotechnology 5
Table 2:OverviewofpublishedBACsystemsformembersofthePoxviridae,Flaviviridae,andCoronaviridaefamily.Commonspeciesnames,
corresponding acronyms, taxon names, genome sizes, and references for the ﬁrst BAC construct of every species are given.
Virus Acronym∗ Taxon name Genome size Reference
Common name∗
Poxviridae
Cowpox virus CPXV Cowpox virus 224kbp [43]
Modiﬁed vaccinia virus Ankara MVA Vaccinia virus 178kbp [40]
Vaccinia virus VAC Vaccinia virus 195kbp [41]
Flaviviridae
Japanese encephalitis virus JEV Japanese encephalitis virus 11kbp [50]
Bovine viral diarrhea virus BVDV Bovine viral diarrhea virus 1 12kbp [47]
Classical swine fever virus CSFV Classical swine fever virus 12kbp [48]
Coronaviridae
Human coronavirus (OC43) HCoV Betacoronavirus 1 31kbp [49]
Severe acute respiratory syndrome coronavirus SARS-CoV Severe acute respiratory syndrome-related
coronavirus 30kbp [46]
Transmissible gastroenteritis coronavirus TGEV Alphacoronavirus 1 29kbp [45]
∗Common names and acronyms are as they were used in the listed reference.
SARS-related coronavirus (SARS-CoV) [46, 49]. Similarly,
the cDNA sequence of Japanese encephalitis virus (JEV),
a member of the Flaviviridae, was cloned into a mini-
F vector in 2003 [50]. Since then, BAC-based genetic
systems have been generated for the pestiviruses bovine
viral diarrhea virus (BVDV) and classical swine fever virus
(CSFV) (Table 2)[ 47, 48].
4. BAC Mutagenesis
4.1. Transposon Mutagenesis. One major advantage of virus
BACs systems is the availability of well-established genetic
tools that allow random and speciﬁc modiﬁcations of the
virusgenomeinE.coli.Onemethodthatallowsmodiﬁcation
of BACs constructs in a nontargeted fashion is transposon-
mediated mutagenesis. Random integration of transposable
elements (Tn) into virus BACs can result in the interruption
of viral genes and sequence elements. The integration of Tn
is mediated by the transposase (tnpA)a n dr e s o l v a s e( tnpR)
gene products of the transposon system [58, 59]. Trans-
poson vectors were generated which contain all required
components for the mutagenesis system. Insertion of various
antibiotic resistance cassettes into the Tn sequence allows the
selection of BAC clones that harbor a transposon insertion.
A temperature-sensitive origin of replication can be utilized
for a rapid removal of the transposon vector. To ensure
that Tn transposition occurs in the BAC construct and not
in the cellular genome, transposons such as Tn1721 have
been developed with a strong preference for circular DNA.
The optimized transposon system can be used to generate
recombinant BAC libraries. The phenotype of mutagenized,
BAC-derived viruses can be subsequently analyzed and
can be used for genome-wide screens. Such screens are
dependent on the available readout systems, but have been
performed for viral genes involved in replication, immune
evasion,andotherprocessesimportant forcompletionoflife
cycles of viruses [60].
4.2. RecA-Based Mutagenesis. To allow a more detailed char-
acterization of viral genes, targeted sequence modiﬁcations
are necessary. Due to the large size of the BAC constructs,
ligation and transformation procedures are usually very
ineﬃcient [61]. To overcome the obstacles, most modiﬁ-
cations of BAC constructs are facilitated by homologous
recombinationtechniquesinE.coli.Thetwowell-established
RecA and Red/RecET recombination systems allow rapid
and convenient modiﬁcations of BAC constructs [7, 62,
63]. The RecA system utilizes cellular RecA recombinase
expressed in bacteria. In order to introduce the desired
modiﬁcation through RecA, long homologous sequences of
500bp to 3kbp are required for recombination events [28,
64]. However, as repetitive sequences are present in many
viruses such as herpesviruses, RecA expression can lead to
rapid destabilization of viral BAC clones. This often results
in the loss of portions of the virus genome. For this reason,
BACs are usually maintained in RecA-deﬁcient E. coli strains,
and the recombinase is only transiently expressed during the
mutagenesis procedure [14, 28, 64].
A common RecA-based mutagenesis technique is termed
shuttle mutagenesis. The system makes use of vectors that
harbor the desired modiﬁcations ﬂanked by sequences
homologous to the target site in the BAC (Figure 1)[ 28,
64]. Recombination of homologous sites is facilitated by
the RecA that usually is encoded by the shuttle vector
[28]. The plasmid regularly harbors a positive and negative
selection marker and often a temperature-sensitive origin
of replication. The plasmid is then transformed into E.
coli containing the desired BAC construct for mutagenesis
to proceed, and bacteria harboring the shuttle vector are
selected using the positive selection marker. Expression of
RecAfacilitatesrecombinationofsequencesthatareidentical
in the shuttle plasmid and the target site in the BAC
construct. Replication of the plasmid can be repressed in a
temperature-dependent manner, and enrichment is achieved6 Journal of Biomedicine and Biotechnology
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Figure1:Schematicillustrationofshuttlemutagenesis.Inaﬁrststep,ashuttleplasmidisinsertedintothetargetsequenceviaRecA-mediated
recombination of homologous sequences. Replication of the shuttle plasmid containing a temperature sensitive origin (oriTS) is repressed
by a temperature increase to 42◦C. Positive co-integrates are selected with corresponding antibiotics. In a second step, vector sequences are
excised from co-integrates by another recombination. Negative selection markers can be used to select BAC constructs that lost the shuttle
plasmid [28, 64]. Dotted lines symbolize recombination events.
of bacteria in which the plasmid sequences were integrated
intotheBAC.Inasecondrecombinationevent,thebackbone
of shuttle vector is excised from the BAC construct. This
can occur with either homologous ﬂank present in shuttle
vector sequences. If the second recombination utilizes the
homologous sequence that was not utilized in the ﬁrst step,
then the desired modiﬁcation is maintained in the BAC
vector (Figure 1)[ 28, 64]. Negative selection markers such
as rspL [65], sacB [66], and tetR [67] in the shuttle vector
backbone can be used to suppress nonresolved BAC clones.
One of the major advantages of shuttle mutagenesis is
that it can be used for the generation of a wide variety of
mutations without leaving any unwanted selection markers
or other bacterial sequences behind. Deletions or modiﬁca-
tion of the target sequence in the BAC can be introduced
within a matter of days. Standard shuttle vectors for speciﬁc
target sites can be generated and rapidly modiﬁed to be used
for introduction of various mutations into a single locus.
Furthermore, the system allows the insertion of short and
long sequences that can be utilized for the development of
vectorvaccines.However,theRecAsystemhasalsoanumber
of disadvantages. The major problem poses the instability
of the BAC clones upon induction of the recombination
system, often resulting in the loss of large portions of the
BAC. The frequency of unwanted recombination events is
increased when negative selection markers are used. Finally,
construction of the shuttle plasmids can be very laborious if
several loci in a BAC construct are targeted for mutagenesis.
4.3.RecombineeringofBACConstructs. Analternativesystem
for the modiﬁcation of BACs in E. coli is the well-established
Red and RecE/T recombination systems that are derived
from bacteriophage λ and the Rac prophage, respectively
[7, 63]. Both systems utilize double-strand DNA (dsDNA)
ends as substrate for the recombination reaction and consist
of three components [7, 63, 68]. The ﬁrst component is
the Gam protein that protects dsDNA ends from degra-
dation in bacteria [69]. A second component is the 5 –3 
exonuclease, alpha or RecE, that generates single-strand 3 
DNA overhangs despite the presence of Gam [70–72]. The
last component is the single-strand binding protein Beta
or RecT. The protein can bind and protect single-strand
DNA from degradation [73–75]. In addition, Beta/RecT
aids in annealing of single-strand DNA to complementary
sequences and in invasion into replication forks with a
preference for lagging DNA strands [76, 77]. The major
advantage of the Red or RecE/T recombination system is that
only short homologous sequences of 30 to 50bp are required
for the recombination to proceed. Furthermore, unwanted
recombinationeventsorrearrangementsoccurrarely,asonly
homologous double-strand ends can be used as a substrate.
For the recombination in bacteria, components of the Red
or RecE/T recombination system can be delivered in trans
by plasmids such as pKD46 that allow inducible expression
of Alpha, Beta and Gam. Once the mutagenesis procedure
is completed, pKD46 can be cured from bacteria by its
temperature-sensitivereplicationmechanism[7,78].Amore
convenient alternative is the use of bacteria containing a
chromosomally encoded λ prophage, such as E. coli strain
DY380 and its derivates. In this case Alpha, Beta, and Gam
canbeinducedinatemperature-dependentmanner[77,79].
The Red or RecE/T mutagenesis system usually utilizes
PCR products that contain a positive selection marker
and sequences homologous to the target site in the BAC
at either end as substrate for recombination. The short
homologoussequencesneededfortargetedinsertionintothe
BAC construct can readily be inserted by 5  overhangs of the
primers used for PCR ampliﬁcation of the selection marker.
The PCR products are then electroporated into E. coli that
harbor the desired BAC construct. Clones that incorporate
the cassette can be selected for the presence of the selectionJournal of Biomedicine and Biotechnology 7
marker. Several mutagenesis techniques have been developed
that often combine Red or RecE/T with other recombination
systems and strategies that allow the removal of unwanted
sequences.
One of these recombination systems that utilize speciﬁc
recognition sites is the Cre/loxP system of bacteriophage
P1. It consists of the Cre recombinase that facilitates
recombination between two 34bp loxP sites [80]. An orthol-
ogous system is based on Flp recombinase derived from
Saccharomyces cerevisiae that utilizes FRT recognition sites
forrecombination[81].ThepresenceoftwoloxP orFRTsites
within a vector results in the excision of sequences ﬂanked
by the recognition sites and can be used for the removal
of unwanted bacterial sequences or selection markers that
were introduced by Red or RecE/T recombination. The
Cre/loxP and FLP/FRT system can also be used for insertion
of sequences. A recombination event between one loxP or
FRT in the BAC construct and the donor sequence allows
insertion of the desired sequences [82, 83]. Expression
plasmidscanbeusedtotransientlyexpresstherecombinases;
alternatively, a number of E. coli strains, such as EL250 and
EL350, that harbor an inducible form of the cre or ﬂp gene in
the chromosome are available [7, 79].
Besides recombination at speciﬁc recognition sites, other
strategies have been developed that allow complete removal
of the introduced marker sequences. One approach utilizes a
combination of positive and negative selection markers [7].
In a ﬁrst Red recombination step, the dual selection cassette
is inserted into the target site. Resulting clones are selected
for the presence of the positive selection marker. In a second
step, a PCR product with the desired modiﬁcation and
ﬂanking homologous sequences for the Red recombination
results in the replacement of the positive and the negative
selection marker. Desired clones can then be enriched by
negative selection, but one disadvantage of the system is the
low eﬃciency of counterselection. In addition, mutations in
the negative selection marker can result in clones that are
resistant to counterselection. Similarly, illegitimate recombi-
nation events removing the counterselection marker without
theinsertionofthesequencemodiﬁcationcanresultinmany
false positive clones.
Analternativeapproachusestwo-wayselectablemarkers,
such as galactokinase (GalK) [84]. The galK gene can be
used as a positive selection marker in E. coli strains such as
SW102 that contain the galactose operon but lack cellular
galK and, therefore, cannot utilize galactose as a carbon
source. In the ﬁrst recombination step, the galK cassette is
introduced into the BAC construct and desired clones are
selected on minimal media containing only galactose as an
energy source. However, galK can also be used as a negative
selection marker as it converts 2-deoxy-galactose (DOG)
to a toxic metabolite, 2-deoxy-galactose-1-phosphate, that
suppresses bacterial growth [84]. This property is used in the
second recombination step as clones can be selected in which
galK is replaced with the desired sequence modiﬁcation.
Besides galK, two other two-way selection markers, thyA and
tolC, can be used in bacteria lacking the corresponding gene
product [85, 86].
ThereisanadditionalRed-basedrecombinationmethod,
en passant mutagenesis, that allows removal of an initially
introduced selection marker cassette [6, 77]. The method is
based on the insertion of a positive selection marker with
an adjacent 18bp I-SceI restriction site and short-sequence
duplications. Short homologous sequences at either end
or the linear marker cassette allow the insertion into the
target site by Red recombination as described above. Next,
expressionofthehomingendonucleaseI-SceIisinducedthat
allows linearization of the BAC construct by the cleavage
of the I-SceI restriction site E. coli. The resulting dsDNA
ends of the BAC serve as a substrate for a second Red
recombination of the duplicated sequences, resulting in the
complete removal of all foreign sequences including the
selection marker [6, 77]. Inducible expression of the I-
SceI enzyme can be accomplished by the use of expression
plasmids or E. coli strains that harbor the I-SceI cassette
chromosomally (e.g., GS1783) [77].
4.4. Deletion of Sequences in BACs. As discussed in
Section 4.3, Red or RecE/T recombination systems provide
a stable and more eﬃcient alternative for the generation
of BAC mutants. For the deletion of sequences from a
BAC construct, a positive selection marker is ampliﬁed by
PCR using primers with 30 to 50bp extensions that are
homologous to the target site in the BAC (Figure 2(a),
light blue and orange boxes) [7]. This PCR product is
electroporated into recombination-competent bacteria that
harbor the BAC clone. The short homologous sequences at
the end of the PCR product are used for two individual
Red recombination events that result in the replacement of
the target sequence with the selection marker. The resistance
gene cassette remains in the BAC and cannot be used for the
mutagenesis of a second locus in the construct (Figure 2(a)).
Another strategy that allows the removal of the resistance
marker utilizes the Cre/loxP and FLP/FRT recombination
systems as described in Section 4.3. For this approach, a
positive selection marker ﬂanked by loxP or FRT sites is
ampliﬁed and introduced into the BAC by homologous
recombination. Induction of the Cre or FLP recombinase
subsequently results in the removal of the marker cassette
from the BAC construct, while only a single loxP or FRT
site remains at the site of deletion (Figure 2(b)). Due to this
residual recognition site, the system can only be applied once
in one and the same BAC construct.
The complete removal of all foreign sequences can be
accomplishedbyenpassant mutagenesis[6,77].Asdescribed
in Section 4.3, a cassette is generated that contains a positive
selection marker with an adjacent I-SceI restriction site. The
cassette is ampliﬁed with primers that not only contain
homologous sequences for the insertion into the target site,
but also a sequence duplication (Figure 2(c), pink and dark
blue boxes) in the 5  overhang. This duplication contains the
site to be deleted and allows the removal of entire marker
cassette in a second Red recombination step [6, 77]. As all
foreign sequences are removed from the site of deletion,
en passant mutagenesis can be utilized for consecutive
modiﬁcations of any locus in a BAC construct.8 Journal of Biomedicine and Biotechnology
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Figure 2: Overview of strategies for the Red-mediated deletion of sequences. Boxes of same color represent identical sequences.
4.5. Insertion of Sequences. Several strategies that allow the
insertion of a sequence of interest (soi) including reporter
genes, ﬂuorescent tags, or foreign, viral antigens into BAC
constructs have been developed (Figure 3). One approach
utilizes a transfer construct that contains the soi and a
positive selection marker ﬂanked again by two loxP or FRT
recognition sites. The construct is inserted into the target
site by Red recombination. In a second step, the selection
marker can be removed by the induction of the Flp or Cre
recombinase, while one recognition site remains in the BAC
construct downstream of the soi (Figure 3(a))[ 7].
Alternatively, a cassette that allows positive and negative
selection or a two-way marker can be inserted at the target
side in a ﬁrst Red recombination event. Subsequently, the
soi with sequences homologous to the target sequence at
either end of the soi facilitates the replacement of the dual
marker cassette with the soi. Clones that have incorporated
thesoicanbeselectedfortheabsenceofthenegativeselection
marker (Figures 3(b) and 3(c))[ 7, 84].
Another method that allows the insertion of a soi into
BAC constructs is en passant mutagenesis [6, 77]. Here, a
transfer construct is generated by the insertion of a positive
selection marker, an adjacent I-SceI site, and a sequence
duplication into a unique restriction site within the soi.
Upon insertion of the transfer cassette, expression of I-SceI
is induced which results in the linearization of the BAC
construct. The sequence duplications allow a second Red
recombination resulting in the removal of all operational
sequences [6, 77]. Existing transfer constructs can be used
fortheinsertionofsoiintoanytargetsequence(Figure 3(d)).
The advantage of the en passant techniques described in this
sectionisthattheyallowtheremovalofselectionmarkerand
can be used to introduce multiple modiﬁcations in a BAC
construct.
4.6. Sequence Editing. The compact organization of viral
genomes is often a challenge for genetic manipulation of
virus BACs. Overlapping coding sequences and regulatory
elements require a strategy that allows the introduction
of minimal sequence modiﬁcations that do not interfere
with the expression and function of neighboring genes
or sequences. In this section, we describe the available
techniques that can be used for speciﬁc, minimal editing of
sequences. The methods allow the manipulation of BACs
on the nucleotide level; they include start codon mutation
or insertion of a stop codon to abrogate gene expression as
well as modiﬁcation of functional domains of proteins or
regulatory elements.
Sequence editing can be achieved by techniques des-
cribed in Section 4.3.A sd e s c r i b e da b o v e ,ad u a lo rt w o -
way selection marker is initially inserted into the target
site in the BAC. In addition, a construct that contains the
target sequence with the desired sequence modiﬁcation is
generated. In a second Red recombination step, the modiﬁed
target sequence is used to replace the negative selection
marker. Counterselection allows the enrichment of clones
that contain the desired mutation (Figures 4(a) and 4(b))
[7, 84]. The advantage of the system is that the same
intermediate clones obtained upon the insertion of the
selection marker cassette can be used to introduce a variety
of modiﬁcations into the same locus. However, false positive
clones can present a problem for the selection of correct
clones as discussed in Section 4.3 [7, 84].Journal of Biomedicine and Biotechnology 9
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Figure 3: Overview of techniques that facilitate the insertion of a sequence of interest (soi) into a target site. Boxes of same color represent
identical sequences.
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Figure 4: Overview of strategies that allow sequence editing of the target sequences. Boxes of same color represent identical sequences.
An alternative technique that allows sequence editing
of the target site is en passant mutagenesis, in which the
selection marker with an adjacent I-SceIi sa m p l i ﬁ e db yP C R
using primers that contain homologous sequences for the
insertion into the target sequence and duplications for the
removal of the marker cassette. The desired modiﬁcations
are included in the center of the duplicated sequences that
are present within primers used for PCR ampliﬁcation
of the selectable marker (Figure 4(c), pink and dark blue
boxes). In the ﬁrst Red recombination, the marker cassette
including the sequence duplications and modiﬁcations are
incorporated into the target site. Upon induction of I-SceI
expression, the sequence duplications allow the removal of
the marker cassette while one duplicated sequence with
the desired sequence modiﬁcations remains in the ﬁnal
construct (Figure 4(c)). The technique can be used to insert
modiﬁcations of up to 50bp in length. Larger modiﬁcation
can be facilitated by the en passant approach described in
Section 4.5 and Figure 3(d) [6, 77].
5. Reconstitution of Virus andMini-F Removal
5.1. Reconstitution of Recombinant Viruses. After mutagen-
esis of the viral genomes in E. coli, recombinant virus can10 Journal of Biomedicine and Biotechnology
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Figure 5: Overview of strategies that allow mini-F removal upon virus reconstitution. Positive selection marker is portion of the BAC vector
backbone. Boxes of same color represent identical sequences.
be reconstituted by transfection of puriﬁed virus BAC DNA
or in vitro transcribed RNA into susceptible eukaryotic cells.
Upon uptake of the virus genome into transfected cells,
virus proteins are expressed and virus replication is initiated.
In some cases, cotransfection of BAC DNA and expression
plasmids encoding transcriptional activators are required to
stimulate virus replication [13]. For poxviruses, infection of
susceptible cells with helperviruses prior to or after trans-
fection is required to achieve reconstitution of recombinant
virus [40–43]. As discussed in Section 2.5, expression of
full-length RNA virus genomes from transfected BAC DNA
can be dependent on the presence of T7 polymerase that is
provided to the transfected cell in trans.
5.2. Site-Speciﬁc Excision of Mini-F Sequences. In case of
DNA viruses, BAC sequences usually remain in the genome
upon reconstitution of the virus. This can have negative
eﬀects on virus replication as, for example, the additional
mini-F sequences might challenge the packaging capacity
of the herpesvirus capsid [87]. In addition, residual bacte-
rial sequences are often unfavorable for some applications
including the development and licensing of life-attenuated
vaccines. For this reason, several strategies have been devel-
oped that allow the excision of the mini-F sequences. One
frequently used approach utilizes the Cre/loxP or FLP/FRT
recombination system (see Section 4.3). For removal of the
mini-F sequences, loxP or FRT sites are inserted at either end
of the mini-F sequences. Cotransfection of the virus BAC
with a Cre or FLP expression plasmid allows the transient
production of the recombinase genes. Upon transfection,
Cre or FLP facilitates removal of the mini-F sequences,
only leaving a scar of a single loxP or FRT site of 34bp
(Figure 5(a))[ 8, 14].
5.3. Delivery of Homologous Sequences In Trans. As e c o n d
method that allows the removal of the mini-F uses the
recombination machinery of eukaryotic cells as described
in Section 2.F o rt h i sa p p r o a c h ,ar e p a i rv e c t o r( o rl i n e a r
PCR product) is generated that contains a 1–4kb fragment
representingtheoriginallocusthatwasusedfortheinsertion
of the mini-F. The construct is then cotransfected with
virus BAC DNA into susceptible cells. In transfected cells,
homologous sequences in the repair vector can recombine
with sequences up- and downstream of the mini-F resulting
in the removal of all vector sequences. Virus plaques that lost
the mini-F sequences can be detected by the loss of visual
markers encoded in the mini-F such as GFP [88]. Mini-F
negativevirusisthenisolated,ampliﬁed,andusedforfurther
experiments. The major advantage of this method is that all
bacterial sequences are removed, and no loxP or FRT sites
remain in the virus genome. However, laborious puriﬁcation
steps are required to obtain clonal virus in which mini-F
sequences were removed. This problem can be minimized by
theinsertionofthemini-Fvectorinanessentialgenethereby
generating a growth advantage for viruses that eliminate
bacterial sequences (Figure 5(b))[ 11, 88].
5.4. Removal of Mini-F via Duplications. Another method
thatallowscompleteremovalofthemini-Frepliconanddoes
not require laborious puriﬁcation steps utilizes sequence
duplications that are inserted into the virus genome. Viral
sequences ﬂanking one end of the mini-F backbone are
directly duplicated at the other end. An intramolecular
recombination event during virus DNA replication allows
theremovalofallbacterialsequences,thusrestoringtheorig-
inal insertion locus in the virus. However, one disadvantage
of direct duplications is that they can serve as a substrateJournal of Biomedicine and Biotechnology 11
for bacterial recombinases, resulting in the instability of the
BAC construct in E. coli (Figure 5(c))[ 87]. To circumvent
this problem, sequence duplications can be inserted in an
invertedorientation.Forthisapproach,a1to3kbpfragment
corresponding to the original insertion site of the mini-F
vector is inserted in inverse orientation between the mini-F
replicon and the antibiotic resistance gene of the backbone.
This antiparallel duplication allows stable maintenance and
modiﬁcation of the BAC in E. coli, while the mini-F
sequences are completely removed from the virus genome by
twointra-orintermolecularrecombinationeventsfacilitated
by recombinases in eukaryotic cells (Figure 5(d))[ 13, 43, 57,
89].
6. Conclusions
Since the establishment of the ﬁrst BAC system in 1997, BAC
technology has contributed substantially to our understand-
ing of the life cycle of large DNA and RNA viruses. Several
techniques have been developed that facilitate the insertion
of mini-F sequences into the virus genome. The methods
allowed the generation of BAC systems for a plethora
of virus species including members of the Herpesvirales,
Poxviridae, Coronaviridae,a n dFlaviviridae. Well-established
mutagenesis techniques described in this paper facilitate a
site-speciﬁc manipulation of the virus genome in E. coli.
Several strategies can be used to introduce any desired
modiﬁcation including deletions of viral or insertions of
foreign sequences. Reconstitution of recombinant viruses
can be accomplished by transfection of puriﬁed BAC DNA
intosusceptiblemammaliancells,whileinsomecaseshelper-
viruses or additional expression vectors are required in this
process. Finally, various techniques have been established
thatallowtheexcisionofthemini-Fsequencesfromthevirus
genomes without leaving unwanted sequence behind.
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